Merck & Co Inc
(LTS:0QAH)
$
131.3
0 (0%)
Market Cap: 249.37 Bil
Enterprise Value: 272.91 Bil
PE Ratio: 20.67
PB Ratio: 5.61
GF Score: 81/100 
Merck & Co Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 09, 2021 / 06:50PM GMT
Release Date Price:
$72.42
(-0.27%)
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst
Okay. Great. We are live. Good afternoon and welcome to the Barclays Global Healthcare Conference. Next up, we are pleased to welcome Merck to a fireside chat today. Joining us from the company is Michael Nally, Chief Marketing Officer, and Peter Dannenbaum is also joining from the IR team. Michael, Peter, thank you very much for the time today.
Michael T. Nally
Merck & Co., Inc. - CMO & Executive VP
Thank you, Carter.
Peter Dannenbaum
Merck & Co., Inc. - VP of IR
Thanks, Carter.
Michael T. Nally
Merck & Co., Inc. - CMO & Executive VP
Great to be here.
Questions & Answers
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst
Right. So I'm looking forward to the conversation. Before we touch on all the individual product opportunities that everybody wants to hear about, I want to ask a few kind of
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers